Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy.

Various, diverse molecules contribute to the tumor microenvironment and influence invasion and metastasis. In this review, the roles of neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) in the tumor microenvironment and sensitivity to therapy will be discussed. The lipocalin family of proteins has many important functions. For example when NGAL forms a complex with MMP-9 it increases its stability which is important in cancer metastasis. Small hydrophobic molecules are bound by NGAL which can alter their entry into and efflux from cells. Iron transport and storage are also influenced by NGAL activity. Regulation of iron levels is important for survival in the tumor microenvironment as well as metastasis. Innate immunity is also regulated by NGAL as it can have bacteriostatic properties. NGAL and MMP-9 expression may also affect the sensitivity of cancer cells to chemotherapy as well as targeted therapy. Thus NGAL and MMP-9 play important roles in key processes involved in metastasis as well as response to therapy. This article is part of a Special Issue entitled: Tumor Microenvironment Regulation of Cancer Cell Survival, Metastasis, Inflammation, and Immune Surveillance edited by Peter Ruvolo and Gregg L. Semenza.

[1]  M. Zanetti,et al.  Lipocalin 2 in cancer: when good immunity goes bad. , 2012, Cancer letters.

[2]  J. Quigley,et al.  Tissue-Infiltrating Neutrophils Constitute the Major In Vivo Source of Angiogenesis-Inducing MMP-9 in the Tumor Microenvironment12 , 2014, Neoplasia.

[3]  W. Herrington,et al.  Neutrophil gelatinase-associated lipocalin in kidney transplantation: A review. , 2015, Transplantation reviews.

[4]  Stephen L. Abrams,et al.  Effects of Ectopic Expression of NGAL on Doxorubicin Sensitivity , 2012, Oncotarget.

[5]  D. Bolignano,et al.  Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. , 2010, Cancer letters.

[6]  R. Konrat,et al.  Lipocalin Q83 reveals a dual ligand binding mode with potential implications for the functions of siderocalins. , 2011, Biochemistry.

[7]  Li Yan,et al.  The High Molecular Weight Urinary Matrix Metalloproteinase (MMP) Activity Is a Complex of Gelatinase B/MMP-9 and Neutrophil Gelatinase-associated Lipocalin (NGAL) , 2001, The Journal of Biological Chemistry.

[8]  Haowen Jiang,et al.  Over‐expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer , 2015, The Prostate.

[9]  A. Leonardi,et al.  The neutrophil gelatinase-associated lipocalin (NGAL), a NF-κB-regulated gene, is a survival factor for thyroid neoplastic cells , 2008, Proceedings of the National Academy of Sciences.

[10]  Y. Kuwahara,et al.  Oxidative stress induced lipocalin 2 gene expression: addressing its expression under the harmful conditions. , 2007, Journal of radiation research.

[11]  J. McCubrey,et al.  Increased NGAL (Lnc2) expression after chemotherapeutic drug treatment. , 2013, Advances in biological regulation.

[12]  K. Suk,et al.  Diverse functional roles of lipocalin-2 in the central nervous system , 2015, Neuroscience & Biobehavioral Reviews.

[13]  Martin J. Mueller,et al.  Arabidopsis lipocalins AtCHL and AtTIL have distinct but overlapping functions essential for lipid protection and seed longevity. , 2014, Plant, cell & environment.

[14]  A. Kohda,et al.  DNA element downstream of the κB site in the Lcn2 promoter is required for transcriptional activation by IκBζ and NF‐κB p50 , 2014, Genes to cells : devoted to molecular & cellular mechanisms.

[15]  Michael R. Green,et al.  A Cell-Surface Receptor for Lipocalin 24p3 Selectively Mediates Apoptosis and Iron Uptake , 2005, Cell.

[16]  J. McCubrey,et al.  Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation , 2014, Oncotarget.

[17]  Myung Ah Lee,et al.  Wnt3a expression is associated with MMP-9 expression in primary tumor and metastatic site in recurrent or stage IV colorectal cancer , 2014, BMC Cancer.

[18]  L. Duvillard,et al.  A case–control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer , 2014, BMC Cancer.

[19]  J. McCubrey,et al.  Participation of the Calcium/Calmodulin-dependent Kinases in Hydrogen Peroxide-induced IκB Phosphorylation in Human T Lymphocytes* , 2002, The Journal of Biological Chemistry.

[20]  K. Dorritie,et al.  STAT transcription factors in normal and cancer stem cells. , 2014, Advances in biological regulation.

[21]  A. Martelli,et al.  Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells. , 2014, Advances in biological regulation.

[22]  F. Aigner,et al.  Upregulation of Neutrophil Gelatinase-Associated Lipocalin in Colorectal Cancer Predicts Poor Patient Survival: Reply , 2014, World Journal of Surgery.

[23]  Aristotelis Tsirigos,et al.  The autophagic tumor stroma model of cancer , 2010, Cell cycle.

[24]  M. Sehested,et al.  Neutrophil Gelatinase-Associated Lipocalin Is Up-Regulated in Human Epithelial Cells by IL-1β, but Not by TNF-α 1 , 2003, The Journal of Immunology.

[25]  Stephen L. Abrams,et al.  Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention , 2013, Leukemia.

[26]  H. Sengeløv,et al.  Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. , 1993, The Journal of biological chemistry.

[27]  T. Westbrook,et al.  Tcf3 promotes cell migration and wound repair through regulation of lipocalin 2 , 2014, Nature Communications.

[28]  Y. Zhang,et al.  NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification. , 2012, Cancer epidemiology.

[29]  Stephen L. Abrams,et al.  Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention , 2014, Oncotarget.

[30]  R. Craven,et al.  Neutrophil Gelatinase-associated Lipocalin (NGAL) Expression Is Dependent on the Tumor-associated Sigma-2 Receptor S2RPgrmc1* , 2012, The Journal of Biological Chemistry.

[31]  J. Cuzick,et al.  Altered Microenvironment Promotes Progression of Preinvasive Breast Cancer: Myoepithelial Expression of αvβ6 Integrin in DCIS Identifies High-risk Patients and Predicts Recurrence , 2013, Clinical Cancer Research.

[32]  J. G. Teodoro,et al.  Induction of Apoptosis by a Secreted Lipocalin That is Transcriptionally Regulated by IL-3 Deprivation , 2001, Science.

[33]  C. Sibata,et al.  Inhibition of the CaM-Kinases augments cell death in response to oxygen radicals and oxygen radical inducing cancer therapies in MCF-7 human breast cancer cells , 2006, Cancer biology & therapy.

[34]  A. Jahanian-Najafabadi,et al.  Lipocalin 2 decreases senescence of bone marrow-derived mesenchymal stem cells under sub-lethal doses of oxidative stress , 2014, Cell Stress and Chaperones.

[35]  D R Flower,et al.  The lipocalin protein family: structure and function. , 1996, The Biochemical journal.

[36]  Stephen L. Abrams,et al.  Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine , 2012, Cell cycle.

[37]  S. K. Choudhuri,et al.  Iron N-(2-hydroxy acetophenone) glycinate (FeNG), a non-toxic glutathione depletor circumvents doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo , 2012, BioMetals.

[38]  Jae-Hyun Park,et al.  Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. , 2012, Cancer cell.

[39]  K. Umezawa,et al.  Novel approaches to target NF-κB and other signaling pathways in cancer stem cells. , 2014, Advances in biological regulation.

[40]  J. McCubrey,et al.  Current treatment strategies for inhibiting mTOR in cancer. , 2015, Trends in pharmacological sciences.

[41]  Jialiang Hu,et al.  Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases , 2007, Nature Reviews Drug Discovery.

[42]  H. Erdjument-Bromage,et al.  An iron delivery pathway mediated by a lipocalin. , 2002, Molecular cell.

[43]  X. Huang,et al.  Parthenolide, an inhibitor of the nuclear factor-κB pathway, ameliorates dextran sulfate sodium-induced colitis in mice. , 2012, International immunopharmacology.

[44]  J. McCubrey,et al.  Activation of the calcium/calmodulin-dependent protein kinases as a consequence of oxidative stress. , 2006, Antioxidants & redox signaling.

[45]  C. Butterfield,et al.  Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  B. Dormanesh,et al.  RETRACTED ARTICLE: The value of U-NGAL expression as a potential prognostic biomarker in patients with renal cancer after neoadjuvant chemotherapy with cisplatin , 2016, Tumor Biology.

[47]  J. Cowland,et al.  Induction of Neutrophil Gelatinase-associated Lipocalin Expression by Co-stimulation with Interleukin-17 and Tumor Necrosis Factor-α Is Controlled by IκB-ζ but neither by C/EBP-β nor C/EBP-δ* , 2010, The Journal of Biological Chemistry.

[48]  D. Richardson,et al.  Iron chelators for the treatment of cancer. , 2012, Current medicinal chemistry.

[49]  J. Cowland,et al.  IL-1β-Specific Up-Regulation of Neutrophil Gelatinase-Associated Lipocalin Is Controlled by IκB-ζ1 , 2006, The Journal of Immunology.

[50]  H. Jaafar,et al.  Pattern of Collagen Fibers and Localization of Matrix Metalloproteinase 2 and 9 during Breast Cancer Invasion , 2014, Tumori.

[51]  Jun Yang,et al.  Neutrophil Gelatinase Associated Lipocalin is an Independent Predictor of Poor Prognosis in Cases of Papillary Renal Cell Carcinoma. , 2015, The Journal of urology.

[52]  D. Bolignano,et al.  Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[53]  I. Chu,et al.  Lipocalin‐2 negatively modulates the epithelial‐to‐mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF‐beta1)/Lcn2/Twist1 pathway , 2013, Hepatology.

[54]  R. Khokha,et al.  Proteolysis during Tumor Cell Extravasation In Vitro: Metalloproteinase Involvement across Tumor Cell Types , 2013, PloS one.

[55]  Qing Gao,et al.  Interleukin 17A Promotes Gastric Cancer Invasiveness via NF-κB Mediated Matrix Metalloproteinases 2 and 9 Expression , 2014, PloS one.

[56]  D. Richardson,et al.  The iron-regulated metastasis suppressor NDRG1 targets NEDD4L, PTEN, and SMAD4 and inhibits the PI3K and Ras signaling pathways. , 2013, Antioxidants & redox signaling.

[57]  T. Igarashi,et al.  Neutrophil gelatinase‐associated lipocalin regulates gut microbiota of mice , 2016, Journal of gastroenterology and hepatology.

[58]  D. Xirodimas,et al.  Mechanism of hypoxia-induced NFκB , 2011 .

[59]  A. Friedl,et al.  Neutrophil Gelatinase-associated Lipocalin in Normal and Neoplastic Human Tissues. Cell Type-specific Pattern of Expression , 1999, The Histochemical Journal.

[60]  Wenshuai He,et al.  Up-regulation of miR-138 inhibits hypoxia-induced cardiomyocyte apoptosis via down-regulating lipocalin-2 expression , 2016, Experimental biology and medicine.

[61]  T. Mak,et al.  Lipocalin 2 performs contrasting, location-dependent roles in APCmin tumor initiation and progression , 2012, Oncogene.

[62]  G. Frühbeck,et al.  Up-regulation of the novel proinflammatory adipokines lipocalin-2, chitinase-3 like-1 and osteopontin as well as angiogenic-related factors in visceral adipose tissue of patients with colon cancer. , 2011, The Journal of nutritional biochemistry.

[63]  Stephen L. Abrams,et al.  Mutations and Deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascades Which Alter Therapy Response , 2012, Oncotarget.

[64]  Chawnshang Chang,et al.  Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling , 2014, Oncogene.

[65]  R. Strong,et al.  Iron Traffics in Circulation Bound to a Siderocalin (Ngal)-Catechol Complex , 2010, Nature chemical biology.

[66]  N. Sousa,et al.  From the periphery to the brain: Lipocalin-2, a friend or foe? , 2015, Progress in Neurobiology.

[67]  I. Stamenkovic,et al.  Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. , 1999, Genes & development.

[68]  G. Zalcman,et al.  RhoA induces MMP-9 expression at CD44 lamellipodial focal complexes and promotes HMEC-1 cell invasion. , 2003, Experimental cell research.

[69]  D. Richardson,et al.  Resistance to the Antineoplastic Agent Gallium Nitrate Results in Marked Alterations in Intracellular Iron and Gallium Trafficking: Identification of Novel Intermediates , 2006, Journal of Pharmacology and Experimental Therapeutics.

[70]  C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment , 2014, Breast Cancer Research.

[71]  V. Čapkun,et al.  Lipocalin‐2 and matrix metalloproteinase‐9 expression in high‐grade endometrial cancer and their prognostic value , 2015, Histopathology.

[72]  Ian R. Drexler,et al.  Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. , 2005, The Journal of clinical investigation.

[73]  L. Pusztai,et al.  Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. , 2009, Cancer research.

[74]  Li Yan,et al.  The Matrix Metalloproteinase-9/Neutrophil Gelatinase-Associated Lipocalin Complex Plays a Role in Breast Tumor Growth and Is Present in the Urine of Breast Cancer Patients , 2005, Clinical Cancer Research.

[75]  B. Aggarwal,et al.  Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer. , 2008, Cancer research.

[76]  Yun Wu,et al.  Relationships of lipocalin 2 with breast tumorigenesis and metastasis , 2011, Journal of cellular physiology.

[77]  G. Rice,et al.  Neutrophil gelatinase‐associated lipocalin (NGAL) an early‐screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor‐induced epithelio‐mesenchymal transition , 2007, International journal of cancer.

[78]  Xiaohai Wang,et al.  Endothelial Cells Enhance Prostate Cancer Metastasis via IL-6→Androgen Receptor→TGF-β→MMP-9 Signals , 2013, Molecular Cancer Therapeutics.

[79]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[80]  Jian Tang,et al.  Effect of Inhibiting NGAL Gene Expression on A549 Lung Cancer Cell Migration and Invasion , 2015 .

[81]  M. Zanetti,et al.  ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-κB-dependent manner , 2011, BMC Cancer.

[82]  M. Katan,et al.  PLCɛ and the RASSF family in tumour suppression and other functions. , 2013, Advances in biological regulation.

[83]  Louis B Harrison,et al.  Impact of tumor hypoxia and anemia on radiation therapy outcomes. , 2002, The oncologist.

[84]  N. Perkins,et al.  Regulation of activity and function of the p52 NF-κB subunit following DNA damage , 2010, Cell cycle.

[85]  D. Zurakowski,et al.  Urinary Biomarkers Predict Brain Tumor Presence and Response to Therapy , 2008, Clinical Cancer Research.

[86]  C. Denkert,et al.  Neutrophil Gelatinase-Associated Lipocalin (NGAL) Predicts Response to Neoadjuvant Chemotherapy and Clinical Outcome in Primary Human Breast Cancer , 2012, PloS one.

[87]  T. Mak,et al.  Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[88]  L. Cui,et al.  Protective effects of neutrophil gelatinase-associated lipocalin on hypoxia/reoxygenation injury of HK-2 cells. , 2011, Transplantation proceedings.

[89]  T. Inaba,et al.  Roles of Bim in Apoptosis of Normal and Bcr-Abl-Expressing Hematopoietic Progenitors , 2004, Molecular and Cellular Biology.

[90]  B. Porse,et al.  Liver is the major source of elevated serum lipocalin‐2 levels after bacterial infection or partial hepatectomy: A critical role for IL‐6/STAT3 , 2015, Hepatology.

[91]  N. Soleimani,et al.  Association between neutrophil geletinase-associated lipocalin and iron deficiency anemia in children on chronic dialysis , 2014, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[92]  T. Muta,et al.  Crucial roles of binding sites for NF-κB and C/EBPs in IκB-ζ-mediated transcriptional activation , 2007 .

[93]  K. Oda,et al.  Matrix Metalloproteinase (MMP)-9 in Cancer-Associated Fibroblasts (CAFs) Is Suppressed by Omega-3 Polyunsaturated Fatty Acids In Vitro and In Vivo , 2014, PloS one.

[94]  Cheng‐Yi Chen,et al.  Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer , 2015, Oncotarget.

[95]  Haixin Hong,et al.  Neutrophil gelatinase-associated lipocalin protects renal tubular epithelial cells in hypoxia–reperfusion by reducing apoptosis , 2014, International Urology and Nephrology.

[96]  E. Li,et al.  Lipocalin 2 promotes the migration and invasion of esophageal squamous cell carcinoma cells through a novel positive feedback loop. , 2015, Biochimica et biophysica acta.

[97]  J. McCubrey,et al.  Calcium/calmodulin-dependent kinase I and calcium/calmodulin-dependent kinase kinase participate in the control of cell cycle progression in MCF-7 human breast cancer cells. , 2005, Cancer research.

[98]  D. Richardson,et al.  The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer. , 2006, Carcinogenesis.

[99]  S. Korsmeyer,et al.  Survival factor-induced extracellular signal-regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[100]  N. Chavez-Tapia,et al.  Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in lung adenocarcinoma , 2015, Tumor Biology.

[101]  Dihua Yu,et al.  Upregulation of neutrophil gelatinase-associated lipocalin by ErbB2 through nuclear factor-kappaB activation. , 2009, Cancer research.

[102]  J. McCubrey,et al.  Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer , 2014, Oncotarget.

[103]  D. Richardson,et al.  The iron-regulated metastasis suppressor, Ndrg-1: identification of novel molecular targets. , 2008, Biochimica et biophysica acta.

[104]  I. Shmulevich,et al.  NGAL decreases E-cadherin-mediated cell-cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells , 2009, Laboratory Investigation.

[105]  R. Strong,et al.  The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. , 2002, Molecular cell.

[106]  A. Favier,et al.  Interactions between doxorubicin and the human iron regulatory system. , 2003, Biochimica et biophysica acta.

[107]  D. Richardson,et al.  Tuning Cell Cycle Regulation with an Iron Key , 2007, Cell cycle.

[108]  M. Lindstrom,et al.  Heterogeneous expression of the lipocalin NGAL in primary breast cancers , 1998, International journal of cancer.

[109]  H. Verspaget,et al.  Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer. , 2007, European journal of cancer.

[110]  M. Moses,et al.  Lipocalin 2: A multifaceted modulator of human cancer , 2009, Cell cycle.

[111]  D. Zurakowski,et al.  Lipocalin 2 promotes breast cancer progression , 2009, Proceedings of the National Academy of Sciences.

[112]  A. Mellor,et al.  Neutrophil Gelatinase-Associated Lipocalin: Its Response to Hypoxia and Association with Acute Mountain Sickness , 2013, Disease markers.

[113]  G. Thomas,et al.  GLI1 Confers Profound Phenotypic Changes upon LNCaP Prostate Cancer Cells That Include the Acquisition of a Hormone Independent State , 2011, PloS one.

[114]  M. Seifert,et al.  Neutrophil gelatinase-associated lipocalin and interleukin-10 regulate intramacrophage Chlamydia pneumoniae replication by modulating intracellular iron homeostasis , 2013, Immunobiology.

[115]  S. Witkin,et al.  Neutrophil gelatinase-associated lipocalin and innate immune responses to bacterial infections , 2015, Medical Microbiology and Immunology.

[116]  A. Toker,et al.  Signaling specificity in the Akt pathway in biology and disease. , 2014, Advances in biological regulation.

[117]  Stephen L. Abrams,et al.  Diverse roles of GSK-3: tumor promoter-tumor suppressor, target in cancer therapy. , 2014, Advances in biological regulation.

[118]  Stephen L. Abrams,et al.  Targeting breast cancer initiating cells: advances in breast cancer research and therapy. , 2014, Advances in biological regulation.

[119]  A. Jahanian-Najafabadi,et al.  Lipocalin-2-mediated upregulation of various antioxidants and growth factors protects bone marrow-derived mesenchymal stem cells against unfavorable microenvironments , 2013, Cell Stress and Chaperones.

[120]  Karan P. Singh,et al.  Family history of non-hematologic cancers among Waldenstrom macroglobulinemia patients: a preliminary study. , 2012, Cancer epidemiology.

[121]  Virgilia Macias,et al.  Prostate cancer outcome and tissue levels of metal ions , 2009, The Prostate.

[122]  I. Papassotiriou,et al.  Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease , 2009, BMC Cancer.

[123]  M. Hermann,et al.  Lipocalin‐2 as mediator of chemokine expression and granulocyte infiltration during ischemia and reperfusion , 2013, Transplant international : official journal of the European Society for Organ Transplantation.

[124]  B. Greene,et al.  Iron chelators in cancer chemotherapy. , 2004, Current topics in medicinal chemistry.

[125]  T. Mak,et al.  Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. , 2010, The Journal of clinical investigation.

[126]  F. E. Bertrand,et al.  NOTCH and PTEN in prostate cancer. , 2014, Advances in biological regulation.

[127]  F. Torti,et al.  Iron and cancer: more ore to be mined , 2013, Nature Reviews Cancer.

[128]  E. Eisenmesser,et al.  Extracellular Vesicles Secreted from Cancer Cell Lines Stimulate Secretion of MMP-9, IL-6, TGF-β1 and EMMPRIN , 2013, PloS one.

[129]  H. Christofk,et al.  Estrogen Receptor (ER)α-regulated Lipocalin 2 Expression in Adipose Tissue Links Obesity with Breast Cancer Progression* , 2014, The Journal of Biological Chemistry.

[130]  H. Tschesche,et al.  The human neutrophil lipocalin supports the allosteric activation of matrix metalloproteinases. , 2001, European journal of biochemistry.

[131]  L. Zang,et al.  Berberine Inhibits Human Hepatoma Cell Invasion without Cytotoxicity in Healthy Hepatocytes , 2011, PloS one.

[132]  J. Barata,et al.  IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia. , 2013, Advances in biological regulation.

[133]  Susan M. Kilroy,et al.  Tumor-Specific Urinary Matrix Metalloproteinase Fingerprinting: Identification of High Molecular Weight Urinary Matrix Metalloproteinase Species , 2008, Clinical Cancer Research.

[134]  J. McCubrey,et al.  Pancreatic cancer stem cells: association with cell surface markers, prognosis, resistance, metastasis and treatment. , 2014, Advances in biological regulation.

[135]  R. Cardiff,et al.  CD44v3,8–10 is involved in cytoskeleton‐mediated tumor cell migration and matrix metalloproteinase (MMP‐9) association in metastatic breast cancer cells , 1998 .

[136]  Y. Furuichi,et al.  A novel small-molecule inhibitor of NF-kappaB signaling. , 2008, Biochemical and biophysical research communications.

[137]  Shun-Fa Yang,et al.  Knockdown of lipocalin‐2 suppresses the growth and invasion of prostate cancer cells , 2013, The Prostate.

[138]  J. S. Kim,et al.  Ursolic acid inhibits nuclear factor-κB signaling in intestinal epithelial cells and macrophages, and attenuates experimental colitis in mice. , 2014, Life sciences.

[139]  V. Sukhatme,et al.  Lipocalin 2 Antagonizes the Proangiogenic Action of Ras in Transformed Cells , 2006, Molecular Cancer Research.

[140]  P. Schjerling,et al.  Possible CaMKK-dependent regulation of AMPK phosphorylation and glucose uptake at the onset of mild tetanic skeletal muscle contraction. , 2007, American journal of physiology. Endocrinology and metabolism.

[141]  J. Barata,et al.  PTEN and leukemia stem cells. , 2014, Advances in biological regulation.

[142]  Zihua Hu,et al.  Identification of Common Transcriptional Regulatory Elements in Interleukin-17 Target Genes* , 2006, Journal of Biological Chemistry.

[143]  A. Friedl,et al.  Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer , 2008, Breast Cancer Research and Treatment.

[144]  S. Asuthkar,et al.  Irradiation-induced angiogenesis is associated with an MMP-9-miR-494-syndecan-1 regulatory loop in medulloblastoma cells , 2014, Oncogene.

[145]  Zhong-ying Shen,et al.  Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion , 2006, Journal of Clinical Pathology.

[146]  S. Batra,et al.  Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia , 2008, British Journal of Cancer.

[147]  Qing-Yuan Sun Ndc80 complex: New evidence for the existence of spindle assembly checkpoint in mammalian oocyte meiosis , 2011, Cell cycle.

[148]  Jayson A. Neil,et al.  Deconstructing mTOR complexes in regulation of Glioblastoma Multiforme and its stem cells. , 2013, Advances in biological regulation.

[149]  J. McCubrey,et al.  The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells , 2015, Oncotarget.

[150]  D. Richardson,et al.  Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation. , 2004, Blood.

[151]  M. Vitale,et al.  Calcium/calmodulin-dependent protein kinase II (CaMKII) phosphorylates Raf-1 at serine 338 and mediates Ras-stimulated Raf-1 activation , 2012, Cell cycle.

[152]  T. Shiozawa,et al.  Lipocalin2 enhances the matrix metalloproteinase-9 activity and invasion of extravillous trophoblasts under hypoxia. , 2013, Placenta.

[153]  Konstantinos Thalassinos,et al.  Comparative analysis of interactions of RASSF1-10. , 2013, Advances in biological regulation.

[154]  A. Look,et al.  Downregulation of Bim, a Proapoptotic Relative of Bcl-2, Is a Pivotal Step in Cytokine-Initiated Survival Signaling in Murine Hematopoietic Progenitors , 2001, Molecular and Cellular Biology.

[155]  Sushovan Guha,et al.  The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. , 2012, Biochimica et biophysica acta.

[156]  D. Richardson,et al.  A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics , 2006, Proceedings of the National Academy of Sciences.

[157]  R. Konrat,et al.  The v-myc-induced Q83 Lipocalin Is a Siderocalin* , 2010, The Journal of Biological Chemistry.

[158]  D. Cameron,et al.  Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer. , 2007, Gynecologic oncology.

[159]  T. Ishigami,et al.  Lipocalin-2 is associated with radioresistance in oral cancer and lung cancer cells. , 2013, International journal of oncology.